Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL).

Tan, D; Diong, C P; Loh, Y; Goh, Y T

Tan, D; Diong, C P; Loh, Y; Goh, Y T.

Afiliação

Tan D; Raffles Cancer Centre, Raffles Hospital, Singapore tan_daryl@rafflesmedical.com.
Diong CP; Department of Haematology, Singapore General Hospital, Singapore, Republic of Singapore.
Loh Y; Raffles Cancer Centre, Raffles Hospital, Singapore.
Goh YT; Department of Haematology, Singapore General Hospital, Singapore, Republic of Singapore.

Ann Oncol ; 27(9): 1811-2, 2016 09.

Article em En | MEDLINE | ID: mdl-27287208

Assuntos

Inibidores de Histona Desacetilases; Inibidores de Proteassoma; Histona Desacetilases; Humanos; Linfoma Extranodal de Células T-NK; Células T Matadoras Naturais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Histona Desacetilases / Inibidores de Proteassoma Limite: Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google